Mercury Systems, Inc. (MRCY) Income Statement

The 2026Q4 revenue of $289.8M represents a sequential acceleration from $235.8M in 2026Q3, but the YoY growth of 6.1% is below the 11.5% seen in the prior quarter. This pattern suggests that while demand is present, the pace of converting backlog to revenue is inconsistent. The record backlog cited by management may indicate future revenue support, but the modest growth relative to that backlog implies execution challenges or timing issues that investors should monitor. The reliance on U.S. defense procurement cycles adds cyclicality, and the recent growth appears more organic than acquisition-driven, given the pivot away from M&A.

The sequential gross margin expansion of over 500 basis points is encouraging, but the absolute level remains low for a specialized defense electronics provider. This suggests a product mix shift toward lower-margin hardware or ongoing pricing pressure from prime contractors. The TTM gross margin of 27.9% is significantly below Curtiss-Wright's 37.2%, indicating that Mercury may be ceding pricing power or facing higher input costs. The sustainability of the 30.6% margin is uncertain, as it may reflect a favorable one-time mix rather than a structural improvement. Investors should monitor whether this level can be maintained as revenue mix evolves.

The positive operating income in 2026Q4 is a notable improvement, but the TTM operating margin of 0.0% indicates that the company is still operating near breakeven. SG&A expenses of $47.8M in 2026Q4 are elevated relative to the gross profit of $88.6M, suggesting that overhead absorption is insufficient at current revenue levels. The high fixed-cost base, driven by R&D and specialized manufacturing, means that operating leverage will only materialize with sustained revenue growth. The recent quarter's improvement may indicate early benefits from the operational pivot, but the durability of this leverage is unproven.

The reduction in COGS ratio is a positive sign, but the combined R&D and SG&A expenses of $64.0M in 2026Q4 represent 22.1% of revenue, which is high for a company with a 30.6% gross margin. This suggests that the cost structure is still too heavy for the current revenue scale, likely due to prior acquisition integration costs and ongoing investment in high-priority programs. The recent leadership change and operational pivot may be aimed at addressing this, but the evidence of sustained cost reduction is limited to one quarter. Investors should monitor whether R&D and SG&A can be scaled down as a percentage of revenue without compromising growth.

The transition from negative operating income in the first three quarters of 2026 to positive in Q4 is a significant inflection point. This improvement was driven by a combination of higher revenue, improved gross margin, and controlled SG&A, suggesting that the operational pivot is beginning to yield results. However, the sustainability of this inflection is uncertain, as it may be influenced by one-time factors such as favorable program milestones or timing of expenses. The record bookings and backlog cited by management provide a foundation for future revenue, but the translation into consistent profitability remains the key test. If the company can maintain operating margins above 4%, it would represent a structural shift from the recent loss-making trend.